FindTrial
Sign In

Cost-effectiveness study of immunosuppressive regimen in solid organ transplant recipients from real-world data

Cost-effectiveness study of immunosuppressive regimen in solid organ transplant recipients from real-world data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009429
Enrollment
20000
Registered
2024-05-14
Start date
2021-06-24
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sungkyunkwan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with a history of solid organ transplantation 2. Adult patients 18 years of age or older

Exclusion criteria

Exclusion criteria: 1) underwent any transplantation within a year before the cohort entry date 2) received CNI or mTORi (sirolimus or everolimus) during the washout window 3) had a human immunodeficiency virus (HIV) infection (B20–24) within a year before the cohort entry date 4) were aged under 18 years on the cohort entry date

Design outcomes

Primary

MeasureTime frame
Immunosuppressive drugs are associated with malignancies—

Secondary

MeasureTime frame
Healthcare utilization/costs for immunosuppressive regimen—

Countries

Korea, Republic of

Contacts

Public ContactSuk-Chan Jang

Sungkyunkwan University

sukchanj@naver.com+1-352-246-3768

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026